Viral illnesses
Epidemiological surveillance, Monkeypox, Peer-reviewed evidence, Resource Type, Statistical evidence, Viral illnesses
Clinical and Laboratory Diagnosis of Monkeypox (mpox): Current Status and Future Directions
Reference: Ribeiro da Silva, S. J., Kohl, A., Pena, L., & Pardee, K. (2023). Clinical and laboratory diagnosis of monkeypox (mpox): Current status and future directions. iScience, 26, 106759. https://doi.org/10.1016/j.isci.2023.106759 Summary: The resurgence of monkeypox (mpox) as a global health concern necessitates a comprehensive understanding of its clinical and laboratory diagnosis. This article reviews the
COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses
Confidential Pfizer Document Reveals Alarming Adverse Events Data
Reference: Horowitz, D. (2023, June 14). Confidential Pfizer document shows the company observed 1.6 million adverse events covering nearly every organ system. Conservative Review. https://www.conservativereview.com/horowitz-confidential-pfizer-document-shows-the-company-observed-1-6-million-adverse-events-covering-n Summary: A recent article by Daniel Horowitz discusses a confidential Pfizer document that reveals the company observed approximately 1.6 million adverse events associated with its vaccine. The document, dated August
COVID-19, Covid-19 vaccines, Genetic vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
The Complexities of mRNA Vaccines: A Gene Therapy Perspective
Reference: Banoun, H. (2023). mRNA: gene therapy or vaccine? SAVIMS (South Africa Vaccine Injury Medicolegal Study Group). Summary: Hélène Banoun’s article delves into the intricate nature of mRNA vaccines, positioning them within the broader context of gene therapy. She explains the dual role of RNA viruses, particularly coronaviruses, in infecting host cells and highlights the